More than 135 cases are currently pending in the Levaquin MDL. The Levaquin cases are currently consolidated in the U.S. District Court for the District of Minnesota. About 6o cases are also pending in state court according to co-lead counsel for the plaintiffs in the MDL.
Levaquin (levofloxancin) is FDA approved to treat a variety of infections. However, the lawsuits claim that the drug causes tendon ruptures among other tendon injuries. The tendon injuries tend to occur more frequently in people over 60 and in those on coritcosteroid therapy. The FDA requested a black box warning for Levaquin in July 2008.
Discovery in 13 bellwether federal court cases is ongoing with the first trial setting in August 2010.
Tuesday, September 22, 2009
Subscribe to:
Comments (Atom)